Small Pharmaceuticals

Morepen Laboratories Ltd.

MOREPENLAB

Market Cap
₹2,912 Cr.
P/E
30.69

Morepen Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
2,912 Cr
PE
PE
30.69
Prom Holding
Prom Holding
35.65 %
ROE (%)
ROE (%)
10.21
ROCE (%)
ROCE (%)
12.80
Div Yield (%)
Div Yield (%)
0.38
Sales
Sales
1,805 Cr
OPM (%)
OPM (%)
6.96 %
Debt to Equity
Debt to Equity
0.07
Institutions
Institutions
2.84 %
Individual < 2 lac
Individual < 2 lac
45.15 %
No. of Shareholders
No. of Shareholders
4.47 L
View more
Edit Ratio's

About

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagno… Read more
Low
33
52W Range
High
66
  • Morepen Laboratories
  • Solara Active Pharma
  • Aarti Drugs
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.07 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
1.58 %
(as of May 19)
Historic
Blood Related - Market Share
0 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.04 %
(as of Nov 21)
Historic
Dermatology - Market Share
0.05 %
(as of Jul 22)
Historic
Gastro-Intestinal - Market Share

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Home Diagnostics / Health

Product Wise Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Product Wise Break-Up - Finished Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Operational Metrics

    locked
    Select a Metric
    • Global DMFs filed (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Burnol

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Novartis India Ltd.

    FAQs on Morepen Laboratories Ltd. Business

    Morepen Laboratories is a pharmaceutical company manufacturing APis, Home Diagnostics, and OTC products. They specialize in anti-allergy drug Loratadine and are prominent in Blood Glucose Monitors and Blood Pressure Monitors domestically.

    Morepen Laboratories major competitors are Solara Active Pharma, Aarti Drugs, SMS Pharmaceuticals, Hester Biosciences, NGL Fine-Chem, IOL Chem & Pharma, Themis Medicare.
    Market Cap of Morepen Laboratories is ₹2,853 Crs.
    While the median market cap of its peers are ₹2,760 Crs.

    Morepen Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Morepen Laboratories is 4.82 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Morepen Laboratories Ltd.
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material